Delivery Order SPE2DB22D1106-SPE2DB25FDTS1

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,091.64, is for the delivery of Albuterol HFA 90 MCG Inhalers and has a completion date of November 22, 2023. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.58 firm fixed-price delivery order covers the procurement of Albuterol HFA 90 MCG inhalers with an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,825.39 firm fixed-price delivery order is for the provision of Albuterol HFA 90 MCG inhalers. The contract has a completion date of December 9, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,151.04 firm fixed-price delivery order is for the supply of Albuterol HFA 90 MCG Inhalers, a critical medical product used for respiratory conditions. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,991.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Albuterol HFA 90 MCG Inhalers, a critical pharmaceutical product used to treat respiratory conditions. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,353.64 firm fixed-price delivery order is for the supply of Albuterol HFA 90 MCG Inhalers, with a period of performance through February 29, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Albuterol HFA 90 MCG Inhalers (8.5 GM) to the Defense Logistics Agency (DLA). The $1,031.01 firm-fixed-price delivery order was issued on December 8, 2022, with a completion date of December 9, 2022. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,297.94 firm fixed price delivery order is for the supply of 4,567,052,772 units of Albuterol HFA 90 MCG inhalers (6.7 grams each) with a completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,441.05 firm fixed-price delivery order is for the supply of 4566265065 - Albuterol HFA 90 MCG Inhaler 18GM. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,120.20, is for the delivery of Albuterol HFA 90 MCG inhalers over the period ending on October 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTS1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,193.56, is for the delivery of Albuterol HFA 90 MCG inhalers. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no mention of any major subcontractors. The DLA, as a defense agency, procures a wide range of medical commodities, including specialty medications, generic drugs, and medical devices, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/13/25, 12:44 AM